Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bepotastine besilate ophthalmic solution 1.5% reduces ocular itching following dosing in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis

Bepotastine besilate ophthalmic solution 1.5% reduces ocular itching following dosing in the Conjunctival Allergen Challenge (CAC) model of acute allergic conjunctivitis. Association for Research in Vision and Ophthalmology Meeting. 2009.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.